How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy

How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy

Five to ten million individuals are infected by Human T-cell Leukemia Virus type 1 (HTLV-1). HTLV-1 is transmitted through prolonged breast-feeding, by sexual contacts and by transmission of infected T lymphocytes through blood transfusion. One to ten percent of infected carriers will develop a seve...

Full description

Bibliographic Details
Main Authors: Amandine Pasquier, Sandrine Alais, Loic Roux, Maria-Isabel Thoulouze, Karine Alvarez, Chloé Journo, Hélène Dutartre, Renaud Mahieux
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-03-01
Series:Frontiers in Microbiology
Subjects:
HTLV-1
antiviral therapy
proviral load
acyclic nucleoside phosphonates and thiophosphonates
AZT
prodrugs
Online Access:http://journal.frontiersin.org/article/10.3389/fmicb.2018.00278/full

Internet

http://journal.frontiersin.org/article/10.3389/fmicb.2018.00278/full

Similar Items